MedTrace Logo

Assessing the Effects of Sublingual Sufentanil 30 µg on Postoperative Recovery

NCT04561375 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2023-12-13

Study results available
· View outcomes & findings →

Summary

A pilot study to evaluate the effect of incorporating sublingual sufentanil into our perioperative opioid regimen for ambulatory orthopedic surgery.

Conditions

  • Knee Arthroscopy

Interventions

DRUG

Sufentanil

30 µg tablet of sublingual sufentanil

DRUG

Fentanyl

50 µg fentanyl

Sponsors & Collaborators

  • The Cleveland Clinic

    lead OTHER

Principal Investigators

  • Sabry Ayad, MD · The Cleveland Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-11
Primary Completion
2022-07-01
Completion
2022-07-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04561375 on ClinicalTrials.gov